P Martásek Selected Research

P Martásek Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 10/2016
2	Multiple Sclerosis 01/2012 - 01/2006
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2009 - 08/2002
1	Menkes Kinky Hair Syndrome (Menkes Disease) 01/2017
1	Atypical Rett Syndrome 01/2016
1	Brain Diseases (Brain Disorder) 01/2016
1	Seizures (Absence Seizure) 01/2016
1	Erythropoietic Protoporphyria 01/2015
1	Liver Failure 01/2015
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 01/2015
1	Hepatoerythropoietic Porphyria 01/2015
1	Porphyrias (Porphyria) 01/2015
1	Feeding and Eating Disorders (Eating Disorder) 01/2013
1	Neuroinflammatory Diseases 01/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011
1	Atherosclerosis 01/2011
1	Neurologic Manifestations (Neurological Manifestations) 01/2009
1	Liver Diseases (Liver Disease) 01/2009
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2009
1	Fibrosis (Cirrhosis) 01/2009
1	Antley-Bixler Syndrome Phenotype 01/2008
1	Acute Intermittent Porphyria (Porphyria, Acute) 01/2007
1	Septic Shock (Toxic Shock Syndrome) 01/2006
1	Arthritis (Polyarthritis) 01/2006
1	Asthma (Bronchial Asthma) 01/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2006
1	Hypertension (High Blood Pressure) 01/2006
1	Respiratory Insufficiency (Respiratory Failure) 01/2006
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 11/2004
1	Congenital Disorders of Glycosylation 01/2003
1	Sepsis (Septicemia) 12/2001
1	Stroke (Strokes) 12/2001
1	Inflammation (Inflammations) 12/2001
1	Rett Syndrome (Rett's Disorder) 08/2001
1	Essential Hypertension 06/2001
1	Reperfusion Injury 05/2000

Drug/Important Bio-Agent (IBA)

4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006 - 05/2000
3	CopperIBA 01/2017 - 08/2002
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 10/2016
2	Heme (Haem)IBA 01/2015 - 01/2011
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2013 - 01/2012
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011 - 06/2001
1	Copper-Transporting ATPasesIBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	Uroporphyrinogen Decarboxylase (Uroporphyrinogen III Decarboxylase)IBA 01/2015
1	protoporphyrin IXIBA 01/2015
1	EnzymesIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Ceruloplasmin (Ferroxidase)IBA 01/2009
1	NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA 01/2008
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 01/2007
1	Vasodilator Agents (Vasodilators)IBA 01/2006
1	Pyruvic Acid (Pyruvate)IBA 11/2004
1	AntibodiesIBA 11/2004
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2004
1	Oxidoreductases (Dehydrogenase)IBA 11/2004
1	Glycoproteins (Glycoprotein)IBA 01/2003
1	Methyl-CpG-Binding Protein 2IBA 08/2001
1	Antihypertensive Agents (Antihypertensives)IBA 06/2001
1	A-factor (Streptomyces)IBA 06/2001
1	Superoxides (Superoxide)IBA 05/2000

Therapy/Procedure

4	Therapeutics 01/2017 - 06/2001
2	Liver Transplantation 01/2015 - 01/2009